Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AKER - STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger


AKER - STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / February 24, 2021 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:

  • Cleveland BioLabs, Inc. (NASDAQ:CBLI) relating to the creation of a combined company between the Company and Cytocom, Inc. ("Cytocom"). Under the terms of the agreement, BioLabs shareholders are expected to own only 39% control of the combined company, with Cyctom shareholders expected to own 61%. Click here for more information: https://www.monteverdelaw.com/case/cleveland-biolabs-inc. It is free and there is no cost or obligation to you.
  • Akers Biosciences, Inc. (NASDAQ:AKER) relating to its proposed acquisition by MyMD Pharmaceuticals. Under the terms of the agreement, Akers shareholders are expected to own only 20% of the combined company. Click here for more information: https://www.monteverdelaw.com/case/akers-biosciences-inc. It is free and there is no cost or obligation to you.
  • Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) relating to its proposed acquisition by Great American Outdoors Group. Under the terms of the agreement, SPWH shareholders will receive $18.00 in cash per share. Click here for more information: https://www.monteverdelaw.com/case/sportsmans-warehouse-holdings-inc. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2021 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/631727/STOCKHOLDER-ALERT-Monteverde-Associates-Continues-to-Investigate-the-Following-Merger

Stock Information

Company Name: Akers Biosciences Inc.
Stock Symbol: AKER
Market: NASDAQ

Menu

AKER AKER Quote AKER Short AKER News AKER Articles AKER Message Board
Get AKER Alerts

News, Short Squeeze, Breakout and More Instantly...